|
answer text |
<p>The Department agreed the list price increase for Synacthen in March 2015.</p><p>The
previous Pharmaceutical Price Regulation Scheme, the current 2019 Voluntary Scheme
for Branded Medicines Pricing and Access and our statutory branded medicines pricing
scheme all have detailed arrangements for how companies can request an increase to
the National Health Service list price for a product.</p><p>Companies must comply
with the rules of the relevant scheme when making a price increase request and all
price increase requests must receive Departmental approval before they can take effect.</p><p>
</p><p> </p><p> </p><p><strong> </strong></p><p><strong> </strong></p>
|
|